The Food and Drug Administration announced Wednesday its intention to remove oral phenylephrine, a common ingredient in ...
Such randomization of patients is to be in a 1:2:2 fashion, as follows: 1.2 mg of Pemvidutide - 38 patients 1.8 mg of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback